Terumo Neuro
Thierry de Bosson joined MicroVention in 2012 as Director EMEA – Operations and Finance. He currently serves as Chief Commercial Officer. He is based at MVE in Saint Germain-en-Laye (France).
Thierry has 20 plus years of experience in the Medical Device Industry. He started his medical device career at Boston Scientific Europe where he held Finance, Operations and Sales & Marketing Management positions in NeuroVascular and Peripheral Interventions before joining Cyberonics (now LivaNova) in 2008 as General Manager for Europe.
Thierry lives in Saint Germain-en-Laye. He was born in Paris and graduated from Paris-La Sorbonne University (Economics) and ESCP Europe (Masters in Business).
This person is not in any offices
Terumo Neuro
1 followers
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the company’s evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care. We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.